ci 922 has been researched along with 5-hydroxy-6,8,11,14-eicosatetraenoic acid in 1 studies
Studies (ci 922) | Trials (ci 922) | Recent Studies (post-2010) (ci 922) | Studies (5-hydroxy-6,8,11,14-eicosatetraenoic acid) | Trials (5-hydroxy-6,8,11,14-eicosatetraenoic acid) | Recent Studies (post-2010) (5-hydroxy-6,8,11,14-eicosatetraenoic acid) |
---|---|---|---|---|---|
9 | 0 | 0 | 648 | 5 | 54 |
Protein | Taxonomy | ci 922 (IC50) | 5-hydroxy-6,8,11,14-eicosatetraenoic acid (IC50) |
---|---|---|---|
Polyunsaturated fatty acid 5-lipoxygenase | Homo sapiens (human) | 2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boctor, AM; Pugsley, TA | 1 |
1 other study(ies) available for ci 922 and 5-hydroxy-6,8,11,14-eicosatetraenoic acid
Article | Year |
---|---|
Effect of CI-922, a potential new antiallergy agent, on arachidonic acid metabolism in vitro.
Topics: 4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine; Adult; Animals; Arachidonate 5-Lipoxygenase; Arachidonic Acid; Arachidonic Acids; Azoles; Calcimycin; Cattle; Histamine Release; Humans; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Indoles; Indomethacin; Leukocytes; Male; Masoprocol; Pyrazoles; Seminal Vesicles; Tetrazoles | 1986 |